Monday, 21 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
AstraZeneca’s Farxiga Wins China Approval for Chronic Kidney Disease
February 10, 2025
Company
Drug
Innovent Biologics Doses First Patient in Higher-Dose Mazdutide Obesity Trial
February 10, 2025
Company
Drug
Shanghai Pharma’s CD20 Antibody Advances to Primary Nephropathy Trial After NMPA Approval
February 10, 2025
Company
Drug
Walvax Biotech Wins NMPA Approval for mRNA and Recombinant COVID-19 Vaccines
February 11, 2025
Company
Deals
Medim Science Raises Funds for Macrophage-Targeting Biologics in Cancer Therapy
February 10, 2025
Drug
Medical Device
China’s Pharmaceutical Industry Sees Revenue Decline Amid Export Shifts
February 10, 2025
Company
Deals
Tibet Duo Rui and Nanjing Heron Forge Pharmaceutical Collaboration in China
February 10, 2025
Company
Drug
CARsgen Therapeutics Launches GMP Manufacturing for CAR-T Cell Therapies in North Carolina
February 10, 2025
Company
Deals
MegaRobo and Danaher Life Sciences Partner on Lab Automation in China
February 10, 2025
Company
Drug
Hengrui Medicine’s HRG2101 Inhaler Wins NMPA Approval for IPF Clinical Trial
February 10, 2025
Company
Deals
U Protech Secures Angel Financing for PROTAC and Molecular Glue Drug Pipeline
February 10, 2025
Company
Deals
J&J China, Tencent Launch Digital Rhinitis Platform “Love Nose e-Station”
February 10, 2025
1
2
…
16
17
18
19
20
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
